Skip to content
Search

Latest Stories

VIEWS FROM THE FRONTLINE: My experience with COVID-19 in pharmacy before self-isolation

The last few weeks have by far been the most demanding and daunting in my five years’ career as a community pharmacist.

Sadly, although community pharmacy prides itself as being right at the heart of our local communities and time and again as healthcare professionals we have gone 'above and beyond', I haven’t seen members of the public show a great deal of respect for those of us who work in the profession. In the past four weeks, there has been a massive increase in incidents of abuse of pharmacists and their colleagues in community pharmacy.


Protection from abuse

Driven perhaps by panic and a sense of insecurity, the majority of the public, from my experience, have largely ignored the idea of social distancing and haven't quite kept to the government guidelines of standing about two meters apart – virtually creating a perfect breeding ground for a higher rate of Covid19 infections.

I was shouted at when I politely asked a lady, who was almost hanging over my head, to stay behind the pharmacy counter. She muttered such unpleasant words aimed at me that they left me deeply hurt, down and dejected for the rest of the day.

Abusive behaviour shouldn’t be tolerated under any circumstances let alone during a pandemic of this scale, when community pharmacists and their teams are having to work long hours and stay behind each night to catch up on the extra workload.

I feel that there is a strong need for enforcement of law to protect community pharmacy staff although it is understandable that these are unprecedented times. I particularly like that the Royal Pharmaceutical Society has demanded police protection for pharmacy teams.

Rising demand

As people scrambled to stockpile medicines and supplies, pharmacy teams had to deal with unprecedented pressure: many pharmacies struggled to manage staff shortages because of colleagues like me who needed to self-isolate while the remaining staff had to work non-stop and long hours to meet rising demand.

I have seen huge public demands for over-the-counter medicines, leaving painkiller shelves virtually empty in most pharmacies - particularly those which had items like paracetamol and co-codamol or children’s calpol and nurofen in them.

This has resulted in situations where I have had to tell anxious and worried mothers that we didn’t have any calpol for their children, which was personally very hard for me to accept.

There has also been a huge surge in the number of people coming in to collect their prescriptions for next two to three months, again due to the fear of having to miss out if pharmacies ran out of stock or decided to close like the GP surgery next door.

PPE in pharmacy

As one of several relief pharmacists covering many branches of a community pharmacy chain, we had the instructions not to wear any face masks or gloves. This meant putting our own lives and those of our families at risk.

I have since raised this issue with the Pharmacy Defence Association (PDA) who have written a letter to the Health Secretary to ensure that pharmacies have adequate number of personal protective equipment (PPE) to protect their staff from being infected with COVID-19.

I was happy when the government announced yesterday that it was going to make PPE widely available. I hope this means sufficient supply for all pharmacies but pharmacy multiples must prioritise their staff over sales.

It astounds me that one needs to raise such hullabaloo over basic rights of professional protection, even at the time of a pandemic.

Given my experience over the past few weeks, I would urge the likes of PDA, RPS and other pharmacy bodies to work together and keep on pressing the government to introduce laws that protect pharmacy professionals and pharmacists get the essential gear that will keep them as well as the patients they serve safe.

COVID-19 has proved that the community pharmacy sector badly needs the protection!

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less